Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

EWTX Edgewise Therapeutics Inc

28,90

0,48 (1,69%)

Vor Marktöffnung

Zuletzt aktualisiert: 15:19:28

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Edgewise Therapeutics Charts.

Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Edgewise Therapeutics Charts.

News Edgewise Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 24 Januar 2025 (7 Tage vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 24 Januar 2025 (7 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 22 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
Mittwoch 22 Januar 2025 (1 Woche vor) • Business Wire

Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025
Montag 13 Januar 2025 (2 Wochen vor) • Business Wire

Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025
Dienstag 7 Januar 2025 (3 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 31 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 30 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 16 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
Montag 16 Dezember 2024 (1 Monat vor) • Business Wire

Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Donnerstag 5 Dezember 2024 (2 Monate vor) • Business Wire

Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024
Dienstag 26 November 2024 (2 Monate vor) • Business Wire

Weitere Edgewise Therapeutics Inc News-Artikel

First Trust Cloud Comput...

Terra Santa Propriedades...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen